Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Perfuze Limited

Ireland

CMS manufacturer 100001191926

Open in the dashboard

General payments

$158,710

28 payments

Research payments

$0

0 payments

Ownership & investment interest

$894,226

20 holdings by physicians or their families

Through program year 2025, Perfuze Limited reported paying $158,710 in general payments and $0 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $99,446 17
2024 General $36,354 6
2023 General $22,910 5

Breakdown

Top recipients General payments · program year 2025
  1. Mouhammad Jumaa Neurology · Toledo, OH $15,123 1 payment
  2. Adnan Qureshi Vascular Neurology · Columbia, MO $13,050 2 payments
  3. Guilherme Dabus Neuroradiology · Miami, FL $11,749 2 payments
  4. Sameer Ansari Vascular & Interventional Radiology · Chicago, IL $11,749 2 payments
  5. Jose Suarez Neurology · Baltimore, MD $10,374 2 payments
  6. Raul Nogueira Vascular Neurology · Pittsburgh, PA $8,401 2 payments
  7. Ajit Puri Neuroradiology · Worcester, MA $5,000 1 payment
  8. Ameer Hassan Vascular Neurology · Harlingen, TX $5,000 1 payment
  9. David Fiorella Neuroradiology · Stony Brook, NY $5,000 1 payment
  10. Tarun Bhalla Neurological Surgery · Cleveland, OH $5,000 1 payment
Specialties paid General payments · program year 2025
  1. Vascular Neurology Psychiatry & Neurology $35,451 36% · 5 practitioners
  2. Neurology Psychiatry & Neurology $25,497 26% · 2 practitioners
  3. Neuroradiology Radiology $21,749 22% · 3 practitioners
  4. Vascular & Interventional Radiology Radiology $11,749 12% · 1 practitioner
  5. Neurological Surgery $5,000 5% · 1 practitioner

Each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2025
  1. Ohio $20,123 20% · 2 recipients
  2. Missouri $13,050 13% · 1 recipient
  3. Florida $11,749 12% · 1 recipient
  4. Illinois $11,749 12% · 1 recipient
  5. Maryland $10,374 10% · 1 recipient

The top 5 of 10 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2023–2025
  1. Consulting Fee $103,776 20 payments
  2. Travel and Lodging $46,134 6 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,800 2 payments
Companies with a similar name General payments · program years 2023–2025
  1. Perfuze Inc NJ, United States $957

Grouped by name only. CMS publishes no corporate ownership, so a shared name does not mean a shared parent.

28 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record